Table 1 Demographic and tumor characteristics of 7582 rectal cancer patients.

From: Identifying the long-term survival beneficiary of preoperative radiotherapy for rectal cancer in the TME era

Character

n

%

Sample size

7582

100.0

Age

 ≤ 65 years

5421

71.5

 > 65 years

2161

28.5

Sex

Male

4649

61.3

Female

2933

38.7

Insurance

No

299

3.9

Yes

7200

95.0

Unknown

83

1.1

CEA

 ≤ 5 ng/mL

3047

40.2

 > 5 ng/mL

2300

30.3

Unknown

2235

29.5

Stage

II

2752

36.3

III

4817

63.5

Unknown

13

0.2

T stage

T0/T1/T2

670

8.8

T3

6065

80.0

T4

804

10.6

Unknown

43

0.6

N stage

N0

2671

35.2

N1

3787

49.9

N2

1111

14.7

Unknown

13

0.2

Tumor differentiation

Grade I/II

5961

78.6

Grade III/IV

827

10.9

Unknown

794

10.5

Tumor size

 ≤ 3 cm

1811

23.9

3–5 cm

2570

33.9

 > 5 cm

2220

29.3

Unknown

981

12.9

Tumor deposits

Negative

6094

80.3

Positive

961

12.7

Unknown

527

7.0

Perineural invasion

Absent

5876

77.5

Present

903

11.9

Unknown

803

10.6

Number of LND

 < 12

1992

26.3

 ≥ 12

5577

73.5

Unknown

13

0.2

Preoperative radiotherapy

No

1516

20.0

Yes

6066

80.0

  1. CEA carcinoembryonic antigen, LND dissected lymph nodes.